Attovia grants 140,000 stock options to CMO

Attovia Therapeutics, Inc. reported that Chief Medical Officer Chen Hubert received a grant of stock options covering 140,000 shares of common stock on August 4, 2026.

Rhea-AI Filing Summary

Attovia Therapeutics, Inc. reported that Chief Medical Officer Chen Hubert received a grant of stock options covering 140,000 shares of common stock on August 4, 2026. The options have an exercise price of $17.00 per share and expire on August 3, 2036. Following this grant, Hubert holds 140,000 options directly. According to the vesting terms, 25% of the options vest on August 4, 2027, with the remaining options vesting in equal monthly installments over the subsequent 36 months, subject to continued service.

Insider Trade Summary

Grant/Award: 140,000 shares

Grant/Award 1 txn

Insider Chen Hubert

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	140,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 140,000 contracts (Direct)

Footnotes (1)

1. F1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.

Key Figures

Options granted: 140,000 options Exercise price: $17.00 per share Expiration date: August 3, 2036 +3 more

6 metrics

Options granted 140,000 options Stock option grant to Chief Medical Officer on August 4, 2026

Exercise price $17.00 per share Exercise price for 140,000 stock options

Expiration date August 3, 2036 Option term end date for the 140,000 options

Initial vesting 25% on August 4, 2027 First vesting tranche of the option grant

Remaining vesting period 36 months Monthly vesting of remaining options after initial 25% vests

Options held after grant 140,000 options Total options directly held by Chen Hubert after this transaction

Key Terms

Stock Option (Right to Buy), exercise price, vesting, monthly installments

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 17.0000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"25% of the options shall vest on August 4, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

monthly installments financial

"remaining options shall vest in equal monthly installments"

Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Attovia Therapeutics (ATTO) disclose about Chen Hubert’s new stock options?

Attovia Therapeutics disclosed that Chief Medical Officer Chen Hubert received a grant of 140,000 stock options on August 4, 2026, with an exercise price of $17.00 per share and expiration on August 3, 2036.

What is the vesting schedule of Chen Hubert’s 140,000 options at ATTO?

The 140,000 options granted to Chen Hubert vest 25% on August 4, 2027. The remaining 75% vest in equal monthly installments over the next 36 months, contingent on his continued service with Attovia Therapeutics.

What is the exercise price of the stock options granted to ATTO’s Chief Medical Officer?

The options granted to Attovia’s Chief Medical Officer carry an exercise price of $17.00 per share. They relate to 140,000 shares of common stock and are structured as a standard stock option (right to buy) award.

How many options does Chen Hubert hold after this Form 4 transaction for ATTO?

After this reported transaction, Chief Medical Officer Chen Hubert holds 140,000 stock options directly. These options were acquired as a grant and are subject to the stated vesting schedule and expiration on August 3, 2036.

When do the newly granted ATTO options to Chen Hubert expire?

The stock options granted to Chen Hubert expire on August 3, 2036. They were granted on August 4, 2026, have an exercise price of $17.00 per share, and vest over approximately four years based on continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/08/2026 - 02:11 PM Accepted by SEC EDGAR 08/06/2026 - 05:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chen Hubert

(Last) (First) (Middle)

C/O ATTOVIA THERAPEUTICS, INC.

1091 INDUSTRIAL ROAD, SUITE 310

(Street)

SAN CARLOS CALIFORNIA 94070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Attovia Therapeutics, Inc. [ ATTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17	08/04/2026		A		140,000		(1)	08/03/2036	Common Stock	140,000	$0	140,000	D

Explanation of Responses:

1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.

	/s/ Steven Chan, Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)